Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SylvainL
    Senior Member
    • Feb 2012
    • 180

    #1

    featureCounts

    Hi all,

    I am using (for the first time) featureCounts to get gene level counts in a RNAseq experiment... It is mouse RNAseq and polyA RNA were extracted...

    A quick look at the results shows up to 15% of reads which are unassigned because of no overlap with any feature.

    Do you normally have the same stats?

    s.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    I just checked one dataset (mouse liver), where ~5% had no feature, ~3% were ambiguously mapped (a non-stranded protocol), and ~19% were not uniquely mapped. ~75% were counted if we exclude unmapped reads. This is similar in a mouse hippocampus dataset that I just checked. Obviously if you include unmapped reads then these percentages would go down a bit.

    So, that unassigned percentage seems a bit high, but perhaps there's a good biological reason for that (e.g., in tumors or sperm).

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #3
      Post #29. Response from Wei Shi (author of featureCounts): http://seqanswers.com/forums/showthr...t=49506&page=2

      Comment

      • SylvainL
        Senior Member
        • Feb 2012
        • 180

        #4
        Hi dpryan,

        I already removed the non uniquely mapped so yes, it's a bit lower if we consider all the mapped reads... and yes, it's sperm...

        So I should not worry :9

        Thanks a lot

        Comment

        • dpryan
          Devon Ryan
          • Jul 2011
          • 3478

          #5
          Yeah, sperm will inherently be different, since you have depletion of mRNAs. My sperm datasets aren't polyA enriched, they're ribo-depleted, so I don't have any numbers for comparison.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-22-2026, 11:13 AM
          0 responses
          24 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 10:48 AM
          0 responses
          20 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          36 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          42 views
          0 reactions
          Last Post SEQadmin2  
          Working...